APOPLUS
InactiveInactive; last annual accounts for fiscal year 2024.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-06-2025, 38 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
38 d early
2023
110 d early
2022
4 d early
2021
16 d early
2020
32 d early
2019
25 d early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 6 accounts on average 38 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
Go further with this company
Who ran this company, and where was it based, on a date before the end?Company as of a date Which other companies belong to the same group?MULTIPHARMA GROUP · 10 companies
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€13,550
2023 · €85,036
Working capital
€43,986▼ 49.3%
2023 · €86,775
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€17,049▲ 72.0%€63,934▲ 275%€17,861▼ 72.1%-€9,819-€12,519▼ 27.5%
Net result€11,210▲ 145%€54,870▲ 389%€78,582▲ 43.2%€85,036▲ 8.2%-€13,550
Equity€25,196▲ 80.2%€57,171▲ 127%€135,753▲ 137%€220,789▲ 62.6%€207,239▼ 6.1%
Total assets€177,886▼ 1.4%€202,881▲ 14.1%€235,416▲ 16.0%€289,496▲ 23.0%€217,623▼ 24.8%
Debt€152,689▼ 8.2%€145,710▼ 4.6%€99,663▼ 31.6%€68,707▼ 31.1%€10,384▼ 84.9%
Working capital-€86,320▼ 0.2%-€60,683▲ 29.7%€11,011€86,775▲ 688%€43,986▼ 49.3%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €12,519 in 2024 against €9,819 in 2023; the loss grows and 2024 has the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €217,623
Fixed assets
€163,253 =
Current assets
€54,370 ▼ 56.9%
Equity and liabilities €217,623
Equity
€207,239 ▼ 6.1%
Debt
€10,384 ▼ 84.9%
Debt's share of the balance-sheet total falls from 23.7% to 4.8%. Equity and debt are lower.
Key figures and ratios
Current ratio
5.24▲
2023 · 3.20
Debt to equity
0.05▼
2023 · 0.31
ROE
-6.5%▼
2023 · 38.5%
ROA
-6.2%▼
2023 · 29.4%
Debt ≤ 1 year
€10,384▼
2023 · €39,469
Income taxes
€51▼
2023 · €128
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | €101 | €102 | €109 | €750 | ▲ 588% |
| Gross operating margin9900 | €17,149 | €64,035 | €17,963 | -€9,710 | -€11,769 | ▼ 21.2% |
| Operating profit (loss)9901 | €17,049 | €63,934 | €17,861 | -€9,819 | -€12,519 | ▼ 27.5% |
| Financial income75/76B | - | €9,000 | €62,926 | €96,118 | €1 | ▼ 100.0% |
| Recurring financial income75 | - | €9,000 | €62,926 | €96,118 | €1 | ▼ 100.0% |
| Financial charges65/66B | - | €2,125 | €1,176 | €1,135 | €981 | ▼ 13.6% |
| Recurring financial charges65 | €2,761 | €2,125 | €1,176 | €1,135 | €981 | ▼ 13.6% |
| Profit (loss) for the period before taxes9903 | €14,287 | €70,809 | €79,612 | €85,164 | -€13,500 | ▼ 116% |
| Income taxes67/77 | €3,077 | €15,940 | €1,029 | €128 | €51 | ▼ 60.5% |
| Profit (loss) for the period9904 | €11,210 | €54,870 | €78,582 | €85,036 | -€13,550 | ▼ 116% |
| Profit (loss) for the period to be appropriated9905 | €11,210 | €54,870 | €78,582 | €85,036 | -€13,550 | ▼ 116% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €177,886 | €202,881 | €235,416 | €289,496 | €217,623 | ▼ 24.8% |
| Fixed assets21/28 | €163,253 | €163,253 | €163,253 | €163,253 | €163,253 | = |
| Financial fixed assets28 | €163,253 | €163,253 | €163,253 | €163,253 | €163,253 | = |
| Current assets29/58 | €14,633 | €39,629 | €72,163 | €126,244 | €54,370 | ▼ 56.9% |
| Amounts receivable within one year40/41 | €7,560 | €7,560 | €71,773 | €116,623 | €49,316 | ▼ 57.7% |
| Trade receivables40 | - | €7,560 | €7,560 | €0 | - | - |
| Other amounts receivable41 | - | - | €64,213 | €116,623 | €49,316 | ▼ 57.7% |
| Cash at bank and in hand54/58 | €4,465 | €32,069 | €390 | €9,621 | €5,054 | ▼ 47.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €177,886 | €202,881 | €235,416 | €289,496 | €217,623 | ▼ 24.8% |
| Equity10/15 | €25,196 | €57,171 | €135,753 | €220,789 | €207,239 | ▼ 6.1% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €17,860 | €17,860 | €17,860 | €17,860 | €17,860 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | - | €16,000 | €16,000 | €16,000 | €16,000 | = |
| Profit (loss) carried forward14 | €1,135 | €20,711 | €99,293 | €184,329 | €170,779 | ▼ 7.4% |
| Amounts payable17/49 | €152,689 | €145,710 | €99,663 | €68,707 | €10,384 | ▼ 84.9% |
| Amounts payable after more than one year17 | €49,983 | €42,391 | €34,799 | €27,206 | - | - |
| Financial debts170/4 | - | €42,391 | €34,799 | €27,206 | - | - |
| Amounts payable within one year42/48 | €100,953 | €100,312 | €61,152 | €39,469 | €10,384 | ▼ 73.7% |
| Current portion of amounts payable after more than one year42 | - | €7,592 | €7,592 | €7,592 | - | - |
| Trade debts44 | €4,046 | €4,857 | €52,034 | €1,633 | €4,972 | ▲ 204% |
| Suppliers440/4 | - | €4,857 | €52,034 | €1,633 | €4,972 | ▲ 204% |
| Taxes, remuneration and social security45 | - | €9,017 | €0 | - | €51 | - |
| Taxes450/3 | - | €9,017 | €0 | - | €51 | - |
| Other amounts payable47/48 | - | €78,846 | €1,526 | €30,243 | €5,361 | ▼ 82.3% |
| Accrued charges and deferred income492/3 | - | €3,008 | €3,712 | €2,032 | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €11,210 | €54,870 | €78,582 | €85,036 | -€13,550 | ▼ 116% |
| Operating cash flow (approximation) | €11,210 | €54,870 | €78,582 | €85,036 | -€13,550 | ▼ 116% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | €27,604 | -€31,678 | €9,231 | -€4,567 | ▼ 149% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
23-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet -€13,550
Net result drops to -€13,550, the lowest in the series.
12-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €85,036 ▲8.2%
Net result €85,036, the highest in the series.
31-12
Financial
Liquidity triplescurrent ratio 3.20
Current ratio from 1.18 to 3.20; short-term debt falls from €61,152 to €39,469.
31-12
Financial
Equity above €200,000Eq €220,789 ▲62.6%
6 profitable years in a row build equity to €220,789.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Liquidity triplescurrent ratio 1.18
Current ratio from 0.40 to 1.18; short-term debt falls from €100,312 to €61,152.
31-12
Financial
Equity above €100,000Eq €135,753 ▲137%
5 profitable years in a row build equity to €135,753.
15-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
29-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
18-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 10 acts read
About the unread acts
We know of 10 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Structure & network
Part of the group
MULTIPHARMA GROUP
10 companies
Group, risk and exposure
Owners and holdings
1 owner · 1 holdingChain of control
- MULTIPHARMA GROUP
- Multipharma
- APOPLUS
Highest known parent: MULTIPHARMA GROUP. The sources do not say who stands above it.
Owners 1
- Multipharmaparent100%
Holdings 1
-
100%
According to the 2024 annual accounts of APOPLUS and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.